Cargando…

Cerebral Changes Occurring in Arginase and Dimethylarginine Dimethylaminohydrolase (DDAH) in a Rat Model of Sleeping Sickness

BACKGROUND: Involvement of nitric oxide (NO) in the pathophysiology of human African trypanosomiasis (HAT) was analyzed in a HAT animal model (rat infected with Trypanosoma brucei brucei). With this model, it was previously reported that trypanosomes were capable of limiting trypanocidal properties...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amrouni, Donia, Meiller, Anne, Gautier-Sauvigné, Sabine, Piraud, Monique, Bouteille, Bernard, Vincendeau, Philippe, Buguet, Alain, Cespuglio, Raymond
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052300/ https://www.ncbi.nlm.nih.gov/pubmed/21408057 http://dx.doi.org/10.1371/journal.pone.0016891

Ejemplares similares

Cerebral and Peripheral Changes Occurring in Nitric Oxide (NO) Synthesis in a Rat Model of Sleeping Sickness: Identification of Brain iNOS Expressing Cells
por: Amrouni, Donia, et al.
Publicado: (2010)

Correction: Cerebral and Peripheral Changes Occurring in Nitric Oxide (NO) Synthesis in a Rat Model of Sleeping Sickness: Identification of Brain iNOS Expressing Cells
por: Amrouni, Donia, et al.
Publicado: (2010)

Correction: Cerebral and Peripheral Changes Occurring in Nitric Oxide (NO) Synthesis in a Rat Model of Sleeping Sickness: Identification of Brain iNOS Expressing Cells
por: Amrouni, Donia, et al.
Publicado: (2010)

Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
por: Murphy, Rhys B., et al.
Publicado: (2016)

Cerebral inducible nitric oxide synthase protein expression in microglia, astrocytes and neurons in Trypanosoma brucei brucei-infected rats
por: Cespuglio, Raymond, et al.
Publicado: (2019)

Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer
por: Hulin, Julie-Ann, et al.
Publicado: (2020)

A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase
por: Ragavan, Vinitha N., et al.
Publicado: (2023)

Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity
por: Lambden, Simon, et al.
Publicado: (2018)

Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study
por: Xuan, Chao, et al.
Publicado: (2016)

Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis
por: Kostourou, V, et al.
Publicado: (2002)

Dimethylarginine dimethylaminohydrolase 1 is involved in spinal nociceptive plasticity
por: D'Mello, Richard, et al.
Publicado: (2015)

Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma
por: Shiozawa, Toshihiro, et al.
Publicado: (2015)

Divergent Dimethylarginine Dimethylaminohydrolase Isoenzyme Expression in the Central Nervous System
por: Kozlova, Alena A., et al.
Publicado: (2021)

Dimethylarginine Dimethylaminohydrolase-1 Transgenic Mice Are Not Protected from Ischemic Stroke
por: Leypoldt, Frank, et al.
Publicado: (2009)

Ligand-Dependent Dynamics of the Active-Site Lid in Bacterial Dimethylarginine Dimethylaminohydrolase
por: Rasheed, Masooma, et al.
Publicado: (2014)

Regulation of dimethylarginine dimethylaminohydrolase 2 expression by NF-κB acetylation
por: Li, Jiaqi, et al.
Publicado: (2021)

Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
por: Xie, Ziang, et al.
Publicado: (2022)

A Functional Variant of the Dimethylarginine Dimethylaminohydrolase-2 Gene Is Associated with Insulin Sensitivity
por: Andreozzi, Francesco, et al.
Publicado: (2012)

Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis
por: Lange, Clemens, et al.
Publicado: (2016)

Overexpression of Dimethylarginine Dimethylaminohydrolase 1 Attenuates Airway Inflammation in a Mouse Model of Asthma
por: Kinker, Kayla G., et al.
Publicado: (2014)

Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
por: Tommasi, S., et al.
Publicado: (2017)

Exploring the role of dimethylarginine dimethylaminohydrolase-mediated reduction in tissue asymmetrical dimethylarginine levels in cardio-protective mechanism of ischaemic postconditioning in rats
por: Kaur, Kamaldeep, et al.
Publicado: (2019)

The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study
por: Lu, Tse-Min, et al.
Publicado: (2011)

The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy
por: Wang, Shiyun, et al.
Publicado: (2022)

Dimethylarginine Dimethylaminohydrolase1 Is an Organ-Specific Mediator of End Organ Damage in a Murine Model of Hypertension
por: Sydow, Karsten, et al.
Publicado: (2012)

A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1
por: Buijs, Nikki, et al.
Publicado: (2017)

Dissecting VEGF-induced acute versus chronic vascular hyperpermeability: Essential roles of dimethylarginine dimethylaminohydrolase-1
por: Wang, Ying, et al.
Publicado: (2021)

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients
por: Mannino, Gaia Chiara, et al.
Publicado: (2019)

Dimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis
por: Park, K, et al.
Publicado: (2009)

Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor/Substrate Homeostasis
por: Chertow, Jessica H., et al.
Publicado: (2015)

MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1
por: Hulin, Julie-Ann, et al.
Publicado: (2017)

Dimethylarginine dimethylaminohydrolase 1 protects PM(2.5) exposure-induced lung injury in mice by repressing inflammation and oxidative stress
por: Gao, Junling, et al.
Publicado: (2022)

Pilot Study of the Association of the DDAH2 −449G Polymorphism with Asymmetric Dimethylarginine and Hemodynamic Shock in Pediatric Sepsis
por: Weiss, Scott L., et al.
Publicado: (2012)

Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis
por: Wu, Yizheng, et al.
Publicado: (2023)

Dimethylarginine Dimethylaminohydrolase/Nitric Oxide Synthase Pathway in Liver and Kidney: Protective Effect of Cyanidin 3-O-β-D-Glucoside on Ochratoxin-A Toxicity
por: Sorrenti, Valeria, et al.
Publicado: (2012)

Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study
por: O'Dwyer, Michael J, et al.
Publicado: (2006)

Assessment of DDAH1 and DDAH2 Contributions to Psychiatric Disorders via In Silico Methods
por: Kozlova, Alena A., et al.
Publicado: (2022)

Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis
por: Chandrasekharan, Unnikrishnan M., et al.
Publicado: (2018)

Inhibition of DDAH1, but not DDAH2, results in apoptosis of a human trophoblast cell line in response to TRAIL
por: Lumicisi, B.A., et al.
Publicado: (2015)

DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats
por: Zhu, Zhen-Dong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_01vomhemv3jjm9e3a6f1pt5tcg